Basic HTML Version
Conclusions
·· The PRO-Kinetic clinical data shows good results on a group
of «Real World» coronary patients, treated consecutively
·· Very few stent thrombosis events (0.4 %) were observed up to six and twelve months
·· TVR and TLR rates were low overall and acceptable even among diabetic patients
·· The PRO-Kinetic clinical data continue to show very good results in a small vessel subgroup
(~ 2.3 mm mean lesion diameter)
·· In a clinical environment of ~ 40 % DES utilization, the data should emphasize
the encouraging safety and clinical performance of PRO-Kinetic for patients
with a wide variety of characteristics and/or clinical syndromes
Source: Prof. Ran Kornowski, oral presentation, ICI 2009